ARTICLE | Company News
U.K. Parliament issues ultimatum to Vertex, NHS, NICE
November 16, 2018 3:54 PM UTC
In a last ditch effort to bring to a close a years-long fight over access to cystic fibrosis drugs in the U.K., a Parliament committee said it would release on Nov. 30 documents it has requested from NHS England, NICE and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) regarding pricing negotiations over the biotech's Orkambi lumacaftor/ivacaftor and other CF drugs if the three parties do not reach a reimbursement agreement by the end of the month.
While the House of Commons Health and Social Care Committee sent the letters Nov. 7, it announced the news Nov. 9...
BCIQ Company Profiles
BCIQ Target Profiles